172 related articles for article (PubMed ID: 2572604)
21. Methods to classify bacterial pathogens in cystic fibrosis.
Bjarnsholt T; Nielsen XC; Johansen U; Nørgaard L; Høiby N
Methods Mol Biol; 2011; 742():143-71. PubMed ID: 21547731
[TBL] [Abstract][Full Text] [Related]
22. Molecular analysis of diversity within the genus Pseudomonas in the lungs of cystic fibrosis patients.
Spasenovski T; Carroll MP; Payne MS; Bruce KD
Diagn Microbiol Infect Dis; 2009 Mar; 63(3):261-7. PubMed ID: 19216939
[TBL] [Abstract][Full Text] [Related]
23. Molecular epidemiology of chronic pulmonary colonisation by Pseudomonas aeruginosa in cystic fibrosis.
Boukadida J; De Montalembert M; Lenoir G; Scheinmann P; Véron M; Berche P
J Med Microbiol; 1993 Jan; 38(1):29-33. PubMed ID: 8418289
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis.
Römling U; Fiedler B; Bosshammer J; Grothues D; Greipel J; von der Hardt H; Tümmler B
J Infect Dis; 1994 Dec; 170(6):1616-21. PubMed ID: 7996008
[TBL] [Abstract][Full Text] [Related]
25. PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients.
Spilker T; Coenye T; Vandamme P; LiPuma JJ
J Clin Microbiol; 2004 May; 42(5):2074-9. PubMed ID: 15131172
[TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales.
Scott FW; Pitt TL
J Med Microbiol; 2004 Jul; 53(Pt 7):609-615. PubMed ID: 15184530
[TBL] [Abstract][Full Text] [Related]
27. Biotinylated DNA probes for exotoxin A and pilin genes in the differentiation of Pseudomonas aeruginosa strains.
Samadpour M; Moseley SL; Lory S
J Clin Microbiol; 1988 Nov; 26(11):2319-23. PubMed ID: 2906943
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity, persistence, and distribution of Pseudomonas aeruginosa genotypes in cystic fibrosis patients.
Fegan M; Francis P; Hayward AC; Fuerst JA
J Clin Microbiol; 1991 Oct; 29(10):2151-7. PubMed ID: 1939566
[TBL] [Abstract][Full Text] [Related]
29. Genomic variation among contemporary Pseudomonas aeruginosa isolates from chronically infected cystic fibrosis patients.
Chung JC; Becq J; Fraser L; Schulz-Trieglaff O; Bond NJ; Foweraker J; Bruce KD; Smith GP; Welch M
J Bacteriol; 2012 Sep; 194(18):4857-66. PubMed ID: 22753054
[TBL] [Abstract][Full Text] [Related]
30. Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa.
Ogle JW; Janda JM; Woods DE; Vasil ML
J Infect Dis; 1987 Jan; 155(1):119-26. PubMed ID: 3098862
[TBL] [Abstract][Full Text] [Related]
31. Molecular identification of Pseudomonas aeruginosa recovered from cystic fibrosis patients.
Douraghi M; Ghasemi F; Dallal MM; Rahbar M; Rahimiforoushani A
J Prev Med Hyg; 2014 Jun; 55(2):50-3. PubMed ID: 25916020
[TBL] [Abstract][Full Text] [Related]
32. Bacteriophages in sputum of cystic fibrosis patients as a possible cause of in vivo changes in serotypes of Pseudomonas aeruginosa.
Ojeniyi B
APMIS; 1988 Apr; 96(4):294-8. PubMed ID: 3130885
[TBL] [Abstract][Full Text] [Related]
33. Significant differences in type IV pilin allele distribution among Pseudomonas aeruginosa isolates from cystic fibrosis (CF) versus non-CF patients.
Kus JV; Tullis E; Cvitkovitch DG; Burrows LL
Microbiology (Reading); 2004 May; 150(Pt 5):1315-1326. PubMed ID: 15133094
[TBL] [Abstract][Full Text] [Related]
34. Epidemiologic characterization of Pseudomonas aeruginosa in patients with cystic fibrosis.
Spencker FB; Haupt S; Claros MC; Walter S; Lietz T; Schille R; Rodloff AC
Clin Microbiol Infect; 2000 Nov; 6(11):600-7. PubMed ID: 11168063
[TBL] [Abstract][Full Text] [Related]
35. Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis.
Barth AL; Pitt TL
J Clin Microbiol; 1995 Jan; 33(1):37-40. PubMed ID: 7699062
[TBL] [Abstract][Full Text] [Related]
36. Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients.
van Belkum A; Renders NH; Smith S; Overbeek SE; Verbrugh HA
FEMS Immunol Med Microbiol; 2000 Jan; 27(1):51-7. PubMed ID: 10617790
[TBL] [Abstract][Full Text] [Related]
37. Use of subtractive hybridization to identify a diagnostic probe for a cystic fibrosis epidemic strain of Pseudomonas aeruginosa.
Parsons YN; Panagea S; Smart CH; Walshaw MJ; Hart CA; Winstanley C
J Clin Microbiol; 2002 Dec; 40(12):4607-11. PubMed ID: 12454160
[TBL] [Abstract][Full Text] [Related]
38. Genetic relatedness of Pseudomonas aeruginosa isolates among a paediatric cystic fibrosis patient cohort in Ireland.
Logan C; Habington A; Lennon G; Grogan J; Byrne M; O'Leary J; O'Sullivan N
J Med Microbiol; 2012 Jan; 61(Pt 1):64-70. PubMed ID: 21921114
[TBL] [Abstract][Full Text] [Related]
39. Strong incidence of Pseudomonas aeruginosa on bacterial rrs and ITS genetic structures of cystic fibrosis sputa.
Pages-Monteiro L; Marti R; Commun C; Alliot N; Bardel C; Meugnier H; Perouse-de-Montclos M; Reix P; Durieu I; Durupt S; Vandenesch F; Freney J; Cournoyer B; Doleans-Jordheim A
PLoS One; 2017; 12(3):e0173022. PubMed ID: 28282386
[TBL] [Abstract][Full Text] [Related]
40. Molecular epidemiological study of Pseudomonas aeruginosa isolates from patients with acute leukemia.
Kern W; Wolz C; Döring G
Eur J Clin Microbiol Infect Dis; 1990 Apr; 9(4):257-61. PubMed ID: 2112464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
